Effects of four different α1-adrenoceptor antagonists on α-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters

Journal of Smooth Muscle Research

Volumn 45, Issue 4, 2009, Pages 187-195

  Kobayashi, Shinya ^a   Tomiyama, Yoshitaka ^a   Maruyama, Kazuyasu ^a   Hoyano, Yuji ^a   Yamazaki, Yoshinobu ^a   Kusama, Hiroshi ^a  

^a KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

1 adrenoceptor antagonists; Contraction; Ureter

Indexed keywords

ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; DOXAZOSIN; DRUG DERIVATIVE; INDOLE DERIVATIVE; NORADRENALIN; PRAZOSIN; QUINAZOLINE DERIVATIVE; SILODOSIN; TERAZOSIN;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DRUG EFFECT; HAMSTER; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; MOUSE; MUSCLE CONTRACTION; PHYSIOLOGY; SYRIAN HAMSTER; URETER;

ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; CRICETINAE; DOXAZOSIN; INDOLES; MALE; MESOCRICETUS; MICE; MICE, INBRED ICR; MUSCLE CONTRACTION; NOREPINEPHRINE; PRAZOSIN; QUINAZOLINES; URETER;

EID: 77949536370     PISSN: 09168737     EISSN: None     Source Type: Journal    
DOI: 10.1540/jsmr.45.187     Document Type: Article

References (25)

1. 1A-adrenoceptor antagonist, tested in a novel rat model. J. Pharmacol. Exp. Ther. 291: 81-91.
2. 1-adrenoceptor antagonist with uroselective properties. J. Pharmacol. Exp. Ther. 300: 478-486.
3. 1-adrenoceptor subtypes in blood vessels of genetically engineered mice. Br. J. Pharmacol. 146: 456-466.
4. Itoh, Y., Kojima, Y., Yasui, T., Tozawa, K., Sasaki, S. and Kohri, K. (2007). Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int. J. Urol. 14: 749-753.
5. 1 adrenoceptors: binding, functional and in vivo studies. Br. J. Pharmacol. 118: 871-878.
6. Kobayashi, S., Tomiyama, Y., Hoyano, Y., Yamazaki, Y., Kusama, H., Itoh, Y., Kubota, Y. and Kohri, K. (2009a). Gene expressions and mechanical functions of (1-adrenoceptor subtypes in mouse ureter. World J. Urol. (in press).
7. 1-adrenoceptor subtypes in dog intravesical ureter. Urol. (in press).
8. Küpeli, B., Irkilata, L., Gürocak, S., Tunç, L., Kiraç, M., Karaoglan, U. and Bozkirli, I. (2004). Does tamsulosin enhance lower ureteral stone clearance with or without shock wave lithotripsy? Urol. 64: 1111-1115.
9. 1-adrenoceptor antagonist in the lower urinary tract. Br. J. Pharmacol. 109: 1282-1289.
10. 1-adrenoceptor antagonists. Eur. Urol. 36: 35-41.
11. Menon, M., Parulkar, B.G. and Drach, G.W. (1998). Urinary lithiasis: etiology, diagnosis and medical management. In: Campbell's Urology, 7th ed. ed. by P.C. Walsh, A.B. Retik, E.D. Jr Vaughan and A.J. Wein, WB Saunders Co., Philadelphia, Vol. 3, pp. 2661-2733.
12. Micali, S., Grande, M., Sighinolfi, M.C., De Carne, C., De Stefani, S. and Bianchi, G. (2006). Medical therapy of urolithiasis. J. Endourol. 20: 841-847.
13. Mohseni, M.G., Hosseini, S.R. and Alizadeh, F. (2006). Efficacy of terazosin as a facilitator agent for expulsion of the lower ureteral stones. Saudi. Med. J. 27: 838-840.
14. Morita, T., Ando, M., Kihara, K. and Oshima, H. (1994). Function and distribution of autonomic receptors in canine ureteral smooth muscle. Neurourol. Urodyn. 13: 315-321.
15. 1-adrenoceptor antagonist, in human prostate and vasculature. J. Urol. 164: 578-583.
16. Pak, C.Y. (1998). Kidney stones. Lancet 13: 1797-1801.
17. Park, H.K., Choi, E.Y., Jeong, B.C., Kim, H.H. and Kim, B.K. (2007). Localizations and expressions of α- 1A, α-1B and α-1D adrenoceptors in human ureter. Urol. Res. 35: 325-329.
18. Pricop, C., Novac, C., Negru, D., Ilie, C., Pricop, A. and Tanase, V. (2004). Can selective alpha-blockers help the spontaneous passage of the stones located in the uretero-bladder junction? Rev. Med. Chir. Soc. Med. Nat. Iasi. 108: 128-133.
19. Sasaki, S., Itoh, Y., Kojima, Y., Kubota, Y., Hayase, M., Kobayashi, M., Tomiyama, Y., Kobayashi, S., Hoyano, Y., Yamazaki, Y. and Kohri, K. (2008). Expression level and role in ureteral contraction of alpha1-adrenoceptor subtypes in human ureter. J. Urol. 179 (Suppl.): 559.
20. 1A- Adrenoceptor subtype selectivity and organ specificity of silodosin (KMD-3213). Yakugaku Zasshi 126: 209-216.
21. Tatemichi, S., Tomiyama, Y., Maruyama, I., Kobayashi, S., Kobayashi, K., Maezawa, A., Kobayashi, M., Yamazaki, Y. and Shibata, N. (2006b). Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia. Neurourol. Urodyn. 25: 792-799.
22. 1-adrenoceptor subtypes in hamster ureter. Eur. J. Pharmacol. 573: 201-205.
23. Ukhal, M., Malomuzh, O. and Strashny, V. (1999). Administration of doxazosin for speedy elimination of stones from lower part of ureter. Presented at XIV Congress of the EAU, Stockholm.
24. Weiss, R.M., Bassett, A.L. and Hoffman, B.F. (1978). Adrenergic innervation of the ureter. Invest. Urol. 16: 123-127.
25. 1-adrenergic blockers for distal ureteral stones. J. Urol. 173: 2010-2012.